183 related articles for article (PubMed ID: 31918259)
21. GSH depletion and consequent AKT inhibition contribute to the Nrf2 knockdown-induced decrease in proliferation in glioblastoma U251 cells.
Jia Y; Wang HD; Wang Q; Ding H; Wu HM; Pan H
Oncol Rep; 2017 Apr; 37(4):2252-2260. PubMed ID: 28260004
[TBL] [Abstract][Full Text] [Related]
22. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
[TBL] [Abstract][Full Text] [Related]
23. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.
Yang WH; Ding CC; Sun T; Rupprecht G; Lin CC; Hsu D; Chi JT
Cell Rep; 2019 Sep; 28(10):2501-2508.e4. PubMed ID: 31484063
[TBL] [Abstract][Full Text] [Related]
24. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.
Xu Y; Wang K; Yu Q
Oncotarget; 2016 Oct; 7(43):70080-70091. PubMed ID: 27661120
[TBL] [Abstract][Full Text] [Related]
25. The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway.
Yang R; Wu Y; Zou J; Zhou J; Wang M; Hao X; Cui H
Oncotarget; 2016 Jun; 7(24):36255-36265. PubMed ID: 27167112
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells.
Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H
Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049
[TBL] [Abstract][Full Text] [Related]
27. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
[TBL] [Abstract][Full Text] [Related]
28. HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
Yang R; Wu Y; Wang M; Sun Z; Zou J; Zhang Y; Cui H
Oncotarget; 2015 Apr; 6(10):7644-56. PubMed ID: 25760078
[TBL] [Abstract][Full Text] [Related]
29. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
30. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells.
Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S
Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393
[TBL] [Abstract][Full Text] [Related]
31. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
32. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
33. TAZ deficiency impairs the autophagy-lysosomal pathway through NRF2 dysregulation and lysosomal dysfunction.
Kim HK; Jeong H; Jeong MG; Won HY; Lee G; Bae SH; Nam M; Lee SH; Hwang GS; Hwang ES
Int J Biol Sci; 2024; 20(7):2592-2606. PubMed ID: 38725855
[TBL] [Abstract][Full Text] [Related]
34. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
35. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
36. A chaperone-like function of FUS ensures TAZ condensate dynamics and transcriptional activation.
Shao Y; Shu X; Lu Y; Zhu W; Li R; Fu H; Li C; Sun W; Li Z; Zhang Y; Cao X; Ye X; Ajiboye E; Zhao B; Zhang L; Wu H; Feng XH; Yang B; Lu H
Nat Cell Biol; 2024 Jan; 26(1):86-99. PubMed ID: 38172614
[TBL] [Abstract][Full Text] [Related]
37. Thymine DNA glycosylase-regulated TAZ promotes radioresistance by targeting nonhomologous end joining and tumor progression in esophageal cancer.
Zhou W; Zhang L; Chen P; Li S; Cheng Y
Cancer Sci; 2020 Oct; 111(10):3613-3625. PubMed ID: 32808385
[TBL] [Abstract][Full Text] [Related]
38. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
[TBL] [Abstract][Full Text] [Related]
39. VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin.
Elaimy AL; Guru S; Chang C; Ou J; Amante JJ; Zhu LJ; Goel HL; Mercurio AM
Sci Signal; 2018 May; 11(528):. PubMed ID: 29717062
[TBL] [Abstract][Full Text] [Related]
40. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
